Technical Analysis for OVID - Ovid Therapeutics Inc.

Grade Last Price % Change Price Change
grade B 10.75 0.19% 0.02
OVID closed up 1.42 percent on Friday, July 20, 2018, on 77 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Earnings due: Aug 9

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical OVID trend table...

Date Alert Name Type % Chg
Jul 20 Hammer Candlestick Bullish 0.19%
Jul 20 Calm After Storm Range Contraction 0.19%
Jul 20 Wide Range Bar Range Expansion 0.19%
Jul 20 Multiple of Ten Bullish Other 0.19%
Jul 20 Outside Day Range Expansion 0.19%
Jul 20 Wide Bands Range Expansion 0.19%
Jul 19 Volume Surge Other 1.61%
Jul 19 Calm After Storm Range Contraction 1.61%
Jul 19 Wide Bands Range Expansion 1.61%
Jul 18 Wide Bands Range Expansion 0.66%

Older signals for OVID ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company. The Company is engaged in developing medicines for patients and families living with rare neurological disorders. Its lead drug candidate is OV101. The Company’s second lead drug candidate is OV935. OV101 (gaboxadol) is a delta-selective GABAA receptor agonist. Ovid is developing OV101 for use in both Angelman syndrome and Fragile X syndrome to potentially restore tonic inhibition and relieve several of the symptoms of these disorders. Ovid has initiated the Phase II STARS trial of OV101 in adults with Angelman syndrome and a Phase I trial in adolescents with Angelman syndrome or Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies.
Is OVID a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.44
52 Week Low 5.28
Average Volume 43,208
200-Day Moving Average 8.7037
50-Day Moving Average 8.6922
20-Day Moving Average 9.271
10-Day Moving Average 10.22
Average True Range 0.634
ADX 32.61
+DI 28.5098
-DI 15.7936
Chandelier Exit (Long, 3 ATRs ) 9.548
Chandelier Exit (Short, 3 ATRs ) 9.592
Upper Bollinger Band 11.3867
Lower Bollinger Band 7.1553
Percent B (%b) 0.84
BandWidth 45.641247
MACD Line 0.6248
MACD Signal Line 0.4542
MACD Histogram 0.1706
Fundamentals Value
Market Cap 263.96 Million
Num Shares 24.6 Million
EPS -4.85
Price-to-Earnings (P/E) Ratio -2.21
Price-to-Sales 0.00
Price-to-Book 1.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.77
Resistance 3 (R3) 12.60 11.74 12.43
Resistance 2 (R2) 11.74 11.22 11.83 12.32
Resistance 1 (R1) 11.24 10.90 11.49 11.41 12.20
Pivot Point 10.38 10.38 10.51 10.47 10.38
Support 1 (S1) 9.88 9.86 10.13 10.05 9.26
Support 2 (S2) 9.02 9.54 9.11 9.14
Support 3 (S3) 8.52 9.02 9.03
Support 4 (S4) 8.69